86868085
Jan 7, 2016
Dec 6, 2016
Dietary supplements; medical foods for dietary management of diseases and conditions; pharmaceuticals, namely, pharmaceutical preparations for the treatment or prevention of Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD), dyslexia, learning disorders, stress, anxiety, Sleep, epilepsy, concentration and attention impairment and mood deterioration; pharmaceutical preparations for the treatment and prevention of diseases and conditions associated with lipid metabolism, hyperlipidemia and hypertriglyceridemia as reducing serum levels of both cholesterol and triglycerides, and for the treatment and prevention of cardiovascular disease (CVD) and coronary heart disease (CHD) as reducing oxidation levels of serum low density lipoproteins (LDL) and macrophage, and by reducing inflammation and hypertension; pharmaceuticals, namely, pharmaceutical preparations for the treatment or prevention of age-associated memory impairment, mild cognitive impairment, pre-Alzheimer's disease, Alzheimer's disease, predementia syndrome, dementia, subjective cognitive decline, early memory impairment, and age related cognitive decline
Pharmaceuticals